Takeda Pharmaceutical Company Limited
Income Statement
| Line Item | Mar 2020 | Mar 2019 |
|---|---|---|
| Revenue | — | — |
| Cost of Revenue | — | — |
| Gross Profit | — | — |
| Gross Margin | — | — |
| Operating Expenses | ||
| Research & Development | — | — |
| SG&A Expense | — | — |
| Operating Income | — | — |
| Operating Margin | — | — |
| Interest Expense | — | — |
| Pretax Income | — | — |
| Income Tax Expense | — | — |
| Net Income | — | — |
| Net Margin | — | — |
| EPS (Basic) | — | — |
| EPS (Diluted) | — | — |
| Shares Outstanding (Basic) | 1.56B | 1.57B |
| Shares Outstanding (Diluted) | 1.56B | 1.57B |
| Dividends Per Share | — | — |